{
    "SPADE_UN_12136": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_12136",
            "Peptide Name": "WV (De Novo Synthesis)",
            "Source": "synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "WVKAAAKAAAKVW",
            "Sequence Length": 13,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.30897850] Gram-positive bacteria:Staphylococcus aureus ATCC 27853(MIC>128μM), Staphylococcus epidermidis ATCC 12228(MIC>128μM), Staphylococcus faecalis ATCC 29212(MIC=64μM), Bacillus subtilis CMCC 63501(MIC>128μM);Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=32μM), Escherichia coli UB 1005 (MIC>128μM), Pseudomonas aeruginosa ATCC 27853(MIC>128μM), Salmonella typhimurium ATCC 14028(MIC>128μM)",
            "Hemolytic Activity": "[Ref.30897850] 1.5% hemolysis at 256μM against human red blood cells",
            "Cytotoxicity": "[Ref.30897850] ①The cell viability of RAW 264.7 induced by WV is 102.5%, 93.5%, 97.8%, 95.7%, 99.3%, 99.6%, 93.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on RAW 264.7 cells (Control samples) is 93.1%, 67.8%, 37.7%, 17.8%, 0%, 1.4% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.②The cell viability of HEK293T induced by WV is 115.2%, 104.3%, 114.5%, 107.6%, 105.8%, 108.0% and 93.8% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on HEK293T cells (Control samples) is 101.4%, 80.1%, 31.9%, 1.4%, 1.4%, 1.8% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidaton",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C68H106N18O14",
            "Mass": 1399.68,
            "PI": 10.3,
            "Net Charge": 3,
            "Hydrophobicity": 0.44,
            "Half Life": "Mammalian:2.8 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.",
            "Literature": [
                {
                    "Title": "Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency",
                    "Pubmed ID": "30897850",
                    "Reference": "Int J Mol Sci. 2019 Mar; 20(6) 1417. Published online 2019 Mar 20. doi 10.3390/ijms20061417",
                    "Author": "Changxuan Shao, Weizhong Li, Peng Tan, Anshan Shan, Xiujing Dou, Deying Ma, Chunyu Liu",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30897850"
                }
            ],
            "Frequent Amino Acids": "AKV",
            "Absent Amino Acids": "CDEFGHILMNOPQRSTUY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 11,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_01724",
                    "Similarity": 1.0,
                    "Sequence": "AAA"
                },
                {
                    "SPADE_ID": "SPADE_UN_23431",
                    "Similarity": 1.0,
                    "Sequence": "AAAK"
                },
                {
                    "SPADE_ID": "SPADE_UN_27016",
                    "Similarity": 1.0,
                    "Sequence": "AAA"
                }
            ]
        }
    }
}